Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort.

    Kolberg JA, Jørgensen T, Gerwien RW, Hamren S, McKenna MP, Moler E, Rowe MW, Urdea MS, Xu XM, Hansen T, Pedersen O, Borch-Johnsen K.

    Diabetes Care. 2009 Jul;32(7):1207-12.PMID: 19564473 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.

    Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G, Chen M.

    Diabetes Res Clin Pract. 2006 Jun;72(3):244-50. Epub 2005 Dec 27.PMID: 16377022 [PubMed - indexed for MEDLINE]Related articles

    3.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    4.

    Inflammatory markers and risk of developing type 2 diabetes in women.

    Hu FB, Meigs JB, Li TY, Rifai N, Manson JE.

    Diabetes. 2004 Mar;53(3):693-700.PMID: 14988254 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women.

    Beulens JW, Rimm EB, Hu FB, Hendriks HF, Mukamal KJ.

    Diabetes Care. 2008 Oct;31(10):2050-5. Epub 2008 Jul 15.PMID: 18628567 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

    Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

    J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491. PMID: 16918824 [PubMed - indexed for MEDLINE]Related articles

    8.

    Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

    Meigs JB, Hu FB, Rifai N, Manson JE.

    JAMA. 2004 Apr 28;291(16):1978-86.PMID: 15113816 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects.

    Kuusisto J, Mykkänen L, Pyörälä K, Laakso M.

    Stroke. 1994 Jun;25(6):1157-64.PMID: 8202973 [PubMed - indexed for MEDLINE]Related articles

    10.

    Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India.

    Marita AR, Sarkar JA, Rane S.

    Mol Cell Biochem. 2005 Jul;275(1-2):143-51.PMID: 16335794 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

    Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF.

    Diabetes. 2003 Mar;52(3):812-7.PMID: 12606524 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

    Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS.

    Diabetes Care. 2003 Jun;26(6):1745-51.PMID: 12766104 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus.

    Ezenwaka CE, Kalloo R, Uhlig M, Eckel J.

    Horm Metab Res. 2004 Apr;36(4):238-42.PMID: 15114523 [PubMed - indexed for MEDLINE]Related articles

    16.

    Fasting plasma free fatty acids and risk of type 2 diabetes: the atherosclerosis risk in communities study.

    Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, Golden SH; Atherosclerosis Risk in Communities Study.

    Diabetes Care. 2004 Jan;27(1):77-82.PMID: 14693970 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fasting proinsulin concentrations predict the development of type 2 diabetes.

    Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN.

    Diabetes Care. 1999 Feb;22(2):262-70.PMID: 10333943 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes?

    Osei K, Rhinesmith S, Gaillard T, Schuster D.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4596-601.PMID: 14557428 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.

    Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T; Funagata study.

    Diabetes Care. 2003 Jul;26(7):2015-20.PMID: 12832305 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.

    Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H.

    Eur J Clin Nutr. 2008 Aug;62(8):953-60. Epub 2007 Jun 6.PMID: 17554248 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data